利用靶向性血栓药物实现对实体瘤血管的选择性栓塞是一种新颖的抗肿瘤策略。
It is a promising anti-tumor strategy to selectively induce thrombosis in tumor vessels by using targeted vascular embolization drug.
随着分子生物学研究的进展，表皮生长因子受体抑制剂、血管内皮生长因子抑制剂等分子靶向药物的研究成为热点之一。
With the advancement of the study of molecular biology, the research of the molecular targeted drugs such as EGFR inhibitor and VEGF inhibitor, become one of the hot spots.
应用推荐